$-0.05
(Market cap
$595 Mln
Revenue (TTM)
$95 Mln
P/E Ratio
1714
P/B Ratio
4.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
294.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0
-
Face value
--
-
Shares outstanding
34,698,795
10 Years Aggregate
CFO
$-201.68 Mln
EBITDA
$-232.89 Mln
Net Profit
$-266.11 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Delcath Systems (DCTH)
| 61.8 | 36.9 | 49.8 | 49.4 | 47.3 | 12.1 | -39.9 |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Delcath Systems (DCTH)
| -16.1 | 186.9 | 15.6 | -53.5 | -56.8 | -15.7 | -89.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Delcath Systems (DCTH)
|
16.3 | 594.7 | 95.4 | 0.5 | 1.4 | 0.5 | 1714 | 4.8 |
| 61.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 90.5 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 176.3 | 10,222.2 | 785.1 | 41.5 | 9.9 | 2 | 251.6 | 4.8 |
Shareholding Pattern
View DetailsAbout Delcath Systems (DCTH)
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic... delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York. Read more
-
CEO & Director
Mr. Gerard J. Michel MBA, MS
-
CEO & Director
Mr. Gerard J. Michel MBA, MS
-
Headquarters
Queensbury, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Delcath Systems (DCTH)
What is the current share price of Delcath Systems Inc (DCTH) Today?
The share price of Delcath Systems Inc (DCTH) is $16.34 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Delcath Systems Inc (DCTH) has given a return of 47.33% in the last 3 years.
What is the current PB & PE ratio of Delcath Systems Inc (DCTH)?
Since, TTM earnings of Delcath Systems Inc (DCTH) is negative, P/E ratio is not available.
The P/B ratio of Delcath Systems Inc (DCTH) is 4.80 times as on 21-Aug-2026, a 25 premium to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
149.06 |
3.62 |
2024 |
-12.98 |
4.98 |
2023 |
-2.00 |
6.06 |
2022 |
-0.97 |
-6.06 |
2021 |
-2.36 |
5.07 |
What is the 52 Week High and Low of Delcath Systems Inc (DCTH)?
The 52-week high and low of Delcath Systems Inc (DCTH) are Rs 17.42 and Rs 8.12 as of 30-Aug-2026.
What is the market cap of Delcath Systems Inc (DCTH)?
Delcath Systems Inc (DCTH) has a market capitalisation of $ 595 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Delcath Systems Inc (DCTH)?
Before investing in Delcath Systems Inc (DCTH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.